Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

ALK Abelló

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 1
Rounds per year 0.02
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Key employees 1

Areas of investment

  • Health Diagnostics
  • Health Care
  • Biotechnology
  • Biopharma
Summary

ALK Abellu00f3 is the famous Corporate Investor, which was founded in 1923. The venture was found in Europe in Denmark. The leading representative office of defined Corporate Investor is situated in the Hu00f8rsholm.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the ALK Abellu00f3, startups are often financed by Sofinnova Partners, Apax Partners. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Lundbeckfonden Ventures, InnoBio Fund. In the next rounds fund is usually obtained by Sofinnova Partners, Lundbeckfonden Ventures, InnoBio Fund.

The top activity for fund was in 2009. The higher amount of exits for fund were in 2012. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - France. Among the most successful fund investment fields, there are Biotechnology, Health Care. Among the most popular portfolio startups of the fund, we may highlight DBV Technologies.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Amorchem Canada, Montréal, Quebec
Baron Capital Management Arizona, Scottsdale, United States
Founder Bank Capital -
Goodpatch Japan, Tokyo
Greenstone Investments Auburn Hills, Michigan, United States
Indigo Investment Corporation Chicago, Illinois, United States
Nosara Capital England, London, United Kingdom
Summer VC -
UK Trade & Investment (UKTI) England, London, United Kingdom
WaterStart Capital Atlanta, Georgia, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

DBV Technologies

Biopharma
Biotechnology
Health Care
Health Diagnostics
$25M05 Jan 2011 Ile-de-France

DBV Technologies

Biopharma
Biotechnology
Health Care
Health Diagnostics
$7M22 Jan 2009 Ile-de-France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ALK Abelló?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 16M
Rounds per year 0.02
Peak activity year 2009
Lead investments 0
Follow on index 0.50
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

DBV Technologies

Biopharma
Biotechnology
Health Care
Health Diagnostics
$25M05 Jan 2011 Ile-de-France

DBV Technologies

Biopharma
Biotechnology
Health Care
Health Diagnostics
$7M22 Jan 2009 Ile-de-France
Crunchbase icon

Content report

The following text will be sent to our editors: